ABSTRACT: Twelve replications of four littermate pigs from a herd naive for porcine reproductive and respiratory syndrome (PRRS) were weaned (10 ± 2 d of age) and penned individually in isolation rooms. Pigs were randomly allotted within litter to one of four dietary soy genistein concentrations (0, 200, 400, and 800 ppm) to quantify the effect of soy genistein on pig growth and virus replication during a viral challenge. Genistein was provided as the soy glycoside, genistin. At 29 ± 2 d of age (4.9 ± 1.4 kg BW), pigs were oronasally inoculated with 10 4.3 PRRS virus/mL from strain JA142 in a 2-mL dose. Blood was collected every 4 d from d 0 to 24 postinoculation and analyzed for serum PPRS virus, interferon activity, and α 1 -acylglycoprotein (AGP) concentrations. Serum virus and interferon peaked at 10 5 virus/mL and 57% protection, respectively, at 4 d postinoculation and then declined steadily. Serum AGP concentration peaked at 12 d postinoculation. Each log increase in serum virus was associated with a reduction of daily gain of 0.034 kg in 5.3-kg pigs and 0.004 kg in 11-kg pigs. As dietary genistein
Introduction
Isoflavones are a subgroup of flavonoids found predominantly in soybeans and clover (Reinli and Block, 1996) , with concentrations ranging from 100 to 5,000 ppm (Wang and Murphy, 1994 2.14 virus per milliliter of serum, P < 0.07) and interferon responded quadratically (28.4, 25.7, 22.8, and 30 .9% protection, P < 0.06) independent of days postinoculation. The AGP concentrations increased (P < 0.01) quadratically with the magnitude of the response to dietary genistein maximized at 12 to 16 d postinoculation. Effects of dietary genistein on daily pig gain and feed intake were dependent on dietary genistein concentration and stage of viremia. Daily pig gains from d 0 to 24 postinoculation were improved as dietary genistein increased, but the magnitude of the response to dietary genistein concentration lessened as the serum virus concentrations were minimized resulting in a linear genistein × period interaction (P < 0.07). Daily feed intakes also were increased quadratically as genistein concentration increased. These data indicate that soy genistein at dietary concentrations of 200 to 400 ppm is an orally active immune modulator that enhances systemic serum virus elimination and body growth in virally challenged pigs.
been shown to elicit antioxidant and estrogenic effects (Harbourne, 1994) . One primary isoflavone found in soybeans and soy feed products (e.g., soybean meal) is genistein. In vitro, genistein elicits potential positive and negative immune-modulating effects. Low concentrations of genistein in vitro have been reported to elicit greater natural killer cell activity (Zhang et al., 1999) and antiviral replication and(or) attachment (Yura et al., 1993) . High concentrations of genistein in vitro have been reported to reduce macrophage and natural killer cell and phagocytosis rates through the inhibition of tyrosine kinase activity (Steele and Brahmi, 1988) and to lower T and B lymphocyte production through the suppression of topoisomerase II (Chang et al., 1995) . Therefore, the objective of this study was to quantify the effects of dietary genistein on pig growth and virus persistence during a viral challenge.
Materials and Methods

Animals
The 12 sets of four littermate pigs from a high-lean strain were obtained from a herd naive (noninfected, nonvaccinated) for porcine reproductive and respiratory syndrome (PRRS) virus. The pigs were weaned at 10 ± 2 d of age and penned individually on slotted floors in 61-× 122-cm pens. Pigs were reared in the disease isolation rooms at the National Animal Disease Center, Ames, IA, to minimize the animals' exposure to other antigens. During the first 3 d after weaning, each pig was administered intramuscularly with 4.4 mg of ceftiofur sodium (Naxcel, Pharmacia & Upjohn Animal Health, Kalamazoo, MI) per kilogram BW/daily. Subsequently, no therapeutic or subtherapeutic antimicrobial agents were provided. A thermal climate of 29 to 24°C was maintained.
At weaning, the pigs were randomly allotted within litter to a basal diet supplemented with one of four dietary concentrations of genistein (0, 200, 400, and 800 ppm). The diets contained nutrient concentrations that met or exceeded the estimated nutrient requirements of high-lean pigs (NRC, 1998) . Pigs were allowed to consume feed and water ad libitum.
Nineteen days following weaning, the pigs were oronasally inoculated with 10 4.3 PRRS virus/mL from strain JA142 in a 2-mL dose (courtesy of William Mengeling, USDA/ARS/National Animal Disease Center, Ames, IA). From d 0 to 24 postinoculation, body temperatures were measured daily in the control pig from each replication using a digital rectal thermometer. Feed intake and weight gain were measured every 4 d pre-and postinoculation. Blood samples were collected via jugular venipuncture before the inoculation and every 4 d after inoculation for determination of serum concentrations of virus, interferon (IFN), and α 1 -acylglycoprotein (AGP). Blood samples also were collected before inoculation and every 8 d after inoculation to determine plasma endotoxin levels. Additional blood samples were collected at weaning, inoculation, and at the removal from test (15 ± 2 kg BW) for serological titer analysis for five major swine pathogens: Actinobacillus pleuropneumoniae, Mycoplasma hyopneumoniae, PRRS virus, swine influenza, and transmissible gastroenteritis virus.
Pigs were killed at a BW of 15 ± 2 kg. Spleens and thymus glands were rapidly removed and weighed. Before the inoculation, two pigs were killed due to refusal to consume feed. After inoculation, one pig died due to a twisted gut, and a second pig was killed due to a joint infection. The Committee on Animal Care at National Animal Disease Center (NADC) and Iowa State University approved the animal care procedures employed.
Experimental Diets
The basal diet consisted of a corn, soy concentrate, and whey mixture fortified with minerals and vita- mins (Table 1 ). The experimental diets consisted of the basal diet supplemented with 0, 200, 400, and 800 ppm soy genistein. Soy genistein was provided primarily in the glycone form, genistin, as an 88.8% pure extract (Wiley Organics, Coshocton, OH) from soybeans. The genistein contents of the basal diet and genistein extract were analyzed via high-performance liquid chromatography (Wang and Murphy, 1994) , reported in Table 2 . The analyzed concentrations of genistein on an aglycone-equivalent basis in the experimental diets were 68, 254, 490, and 811 ppm, respectively.
Serological Antibodies to Common Swine Pathogens
The presence of serum antibody titers for PRRS, transmissible gastroenteritis, swine influenza virus, Mycoplasma hyopneumoniae, and Actinobacillus pleuropneumoniae were determined by the Iowa State University Veterinary Diagnostic Laboratory, Ames, according to methods outlined by Greiner et al. (2000) . These samples were taken to verify that the animals did not have passive or active titers for PRRS prior to inoculation and to determine the status of the pigs exposed to other prevalent pig antigens monitored.
Serum Virus and Immune Parameters
Serum PRRS virus concentrations were analyzed using the procedures provided by William Mengeling, USDA/ARS/NADC, as described by Greiner et al. (2000) . Serum IFN concentrations were assayed using a modified cell bioassay (Rubinstein et al., 1981) as described by Greiner et al. (2000) . A 1:32 dilution was used in the assay. Interferon-gamma represented an average of 62% of the total IFN present in the serum. Serum AGP concentrations were analyzed via a radial-immunodiffusion assay (Cardiotech Services Inc., Louisville, KY) as described by Greiner et al. (2000) . The plasma endotoxin was analyzed by a Limulus amebocyte lysate ELISA colorimetric kit (DiaPharma, Franklin, OH). The endotoxin recovery in the assay was 75%, and the detection sensitivity of the assay was 0.005 to 1.2 endotoxin units/mL. Fukui et al. (1989) describes the calculation needed to convert endotoxin units to nanograms.
Data Analysis
Pigs were placed into blocks by litters and then randomly allotted within litter to one of four dietary treatments. Data were analyzed as a randomized complete block design by analysis of variance technique using the GLM procedure of SAS (SAS Inst. Inc., Cary, NC). Pig weight at inoculation was used as a covariate when analyzing pig performance and immune parameters postinoculation. Responses of body weight gain; feed intake; gain/feed; serum concentrations of virus, IFN, and AGP; as well as plasma concentration of endotoxin over the 4-d periods were analyzed as repeated measures. The error terms used to test the effects of genistein, period, and genistein × period were, respectively, replicate × genistein, replicate × period, and replicate × genistein × period.
The relationship of serum virus concentrations, pig performance traits, and immune response was analyzed by multiple regression techniques using the backwards stepwise regression model procedures of SAS (SAS Inst. Inc.). Variables that were not significant (P > 0.10) were deleted from the regression model. The independent variables included in the analysis were the linear and quadratic effects of serum concentrations of virus, IFN, and AGP, and BW for d −4 to 24 postinoculation. The dependent variables were pig BW gain and feed intake for each 4-d period immediately preceding the measurement of the independent variable from −4 to 24 d postinoculation. The pig was considered the experimental unit. Data were reported as least square means.
Results and Discussion
Serological Titer Status
Serological results confirmed that pigs were PRRSnaive at weaning and immediately before inoculation. Based on the level of serum antibody titers, pigs also were naive for Actinobacillus pleuropneumoniae and Mycoplasma hyopneumoniae at weaning, preinoculation, and at 15 kg BW. Passively acquired antibody titers for transmissible gastroenteritis virus and swine influenza virus were present in 50% and 58% of the pigs at weaning and inoculation, respectively; these amounts subsequently declined to 25% and 42% of the animals at 15 kg BW.
Effect of Virus Inoculation
Pigs were not infected until 29 d of age to ensure that the immune system was developed and functional in the experimental animals (Varley, 1995) . Pigs were fed their experimental diets pre-and postinoculation to allow potential effects of genistein on the animals' initial susceptibility to the virus as well as the animals' subsequent ability to eliminate the virus postinoculation to be expressed.
Within 4 d postinoculation, pigs experienced elevated body temperature (∼40.6°C), coughing, and anorexia (Figure 1 ). In agreement with our previous report (Greiner et al., 2000) , pig's serum viral concentration peaked at 4 d postinoculation (10 5 /mL of blood) and then declined linearly. The PRRS virus was detected in serum for 100% and 50% of the pigs at d 4 and 24 postinoculation, respectively. Serum concentrations of IFN, which has antiviral effects and can stimulate macrophage activity, peaked at 4 d postinoculation (94.4% protection) in correspondence with virus concentration, which was similar to that of Greiner et al. (2000) . Serum AGP, however, did not peak until 8 to 12 d postinoculation (845 g/mL). This response was expected, because AGP is produced by the liver in response to the release of cytokines IL-1, IL-6, and tumor necrosis factor-α from the macrophages and requires 8 to 12 d to be synthesized and released into circulation (Kuby, 1997) . Serum concentrations of endotoxin remained low during the 24-d postinoculation period compared with the preinoculation concentrations, indicating that a secondary E. coli infection did not occur (Figure 2) .
Daily weight gain of pigs decreased from 250 g for the 4-d period preceding inoculation to 100 g for the initial 4-d period after inoculation. Subsequently, daily pig gain increased gradually but did not exceed 250 g until d 12 postinoculation (Figure 3) . Feed intake also was suppressed for 8 d postinoculation (Figure 4) .
Based on these data, we find that the viral exposure used in the current study created a prolonged and substantial immune response and resulted in growth 
Dietary Genistein and Genistein × Day Postinoculation Effects
Preinoculation (weaning to inoculation) weight gain and feed intake of pigs decreased linearly (P < 0.06) as genistein concentrations increased (Table 3) . However, mean pig weight did not differ among dietary treatments on the day of inoculation (P > 0.3).
Postinoculation (d 0 to 24 postinoculation), incremental additions of dietary genistein resulted in a linear reduction (P < 0.07) in serum concentration of virus ( Figure 5 ) and a quadratic reduction (P < 0.01) in serum concentration of IFN (Figure 6 ). These responses were independent of postinoculation day. Di- etary genistein additions also resulted in an increase in serum concentration of AGP during the periods of high viremia; however, this response was eliminated as serum virus concentration declined, resulting in a quadratic (P < 0.01) dietary genistein × period interaction (Figure 7) .
Following the inoculation, dietary genistein additions improved daily weight gain and daily feed intake (Table 4) , but the magnitude of the response was dependent on the genistein concentration and days postinoculation (Figure 8 for weight gain, Figure 9 for feed intake). Specifically, BW gain during the stages of high viremia (d 4 to 12 postinoculation) increased as dietary genistein concentration increased; however, responses to 400 and 800 ppm genistein were minimized during stages of low viremia (d 16 to 24 postinoculation), resulting in a dietary genistein × period interaction (P < 0.07).
As dietary soy genistein increased, thymus weight was not altered (P > 0.80), but spleen weight was (Table 4 ). The increase in spleen weight is indicative of a greater B cell production. This response was in agreement with the greater AGP concentration in genistein-fed pigs during the infection period.
The lack of a genistein × day interaction indicates that the serum virus concentration was reduced at 4 d postinoculation by genistein and that the subsequent rate of virus elimination among dietary treatment groups was similar. The lack of interaction indicates that the feeding of genistein preinoculation aided the pig's ability to initially resist virus infection and(or) inhibit viral replication. The greater AGP response in the genistein-fed pigs supports the hypothesis of a greater and more effective immune response, which in turn was associated with a lower virus infection in these animals. The lower level of virus infection in the genistein-fed pigs was associated with increased body growth and voluntary feed intake, particularly during periods of high viremia. The increase in body weight gain and feed intake mimic the improved growth rates observed in pigs as the level of chronic subclinical pathogen exposure is minimized (Williams et al., 1997) . Greiner et al. (2000) reported that minimizing the level of serum PRRS virus concentration by 1 log within the first 4 d postinoculation increased 4-d pig weight gain in similar weight pigs by 0.047 kg. The improvement in weight gain by each additional logarithmic reduction in virus would result in an exponential increase in pig weight gain (Greiner et al., 2000) . In the current study, a reduction in serum virus concentration occurred in the three genistein treatment groups. Based on the regression analysis performed (Table 5) , each logarithmic reduction in serum virus was associated with an improvement in daily gain of 0.034 kg in 5.3-kg pigs, and 0.004 kg in 11-kg pigs, which indicates that genistein addition can improve pig gain during stages of viremia by minimizing, not eliminating, the serum concentration of virus.
The Potential Role of Genistein on Reducing Virus Concentration
The effect of dietary genistein on reducing virus concentration may be related to its effect on the function and intercellular signaling capacity of immune cells and(or) the ability of the virus to replicate or attach. In vitro, low concentrations of genistein (0.5 to 5 M) stimulate natural killer cell activity (Zhang et al., 1999) , which has a key role in pathogen clearance (Kuby, 1997) . Through the activity of natural killer cells, the pathogen is more rapidly removed from the body, which allows the animal to return to its state of health prior to infection (Kuby, 1997) . Genistein also has been shown in vitro at concentrations of more than 25 M to inhibit the protein replication or attachment of the herpes virus (Yura et al., 1993) . Previous work at our station has shown that dietary genistein additions of 120 to 920 ppm result in serum concentrations of 0.5 to 3.5 M in pigs (Cook, 1998) . These serum concentrations represent bioactive levels based on the work of Zhang et al. (1999) .
The lower serum IFN concentrations in genisteinfed animals are in agreement with the greater virus elimination and potentially more rapid return of IFN secretion to baseline levels because IFN is released by T-cytotoxic, T-helper, and natural killer cells in animals exposed to virus (Kuby, 1997) . The more rap-idly and efficiently the virus is decreased, the more rapidly the IFN release is reduced because IFN is released during a pathogen challenge (Kuby, 1997) . The lower IFN concentration could also be due in part to a genistein-induced inhibition of prostaglandin E 2 production (Corbett et al., 1996) .
Because of the 8-to 12-d delay in AGP synthesis and release following a pathogen exposure, the greater serum AGP concentrations 8 to 12 d postinoculation in pigs fed genistein indicates a greater initial capacity of the genistein-fed pigs to mount an immune response. The AGP response is due to the fact that AGP is produced as a result of increased B cell-stimulating cytokines (Kuby, 1997) . The rapid return of serum AGP concentration to baseline values in the genisteinfed pigs is compatible with a lower serum virus concentration.
Implications
Based on these data, we find that soy genistein (200 ppm) is an orally active immune modulator that can reduce virus replication and improve growth in virally challenged animals. The ingestion level of soy isoflavones may improve the biological response of animals to pathogens and(or) vaccines.
